drugset / Trial / NCT00834470

Adjunctive Atropine During Ketamine Sedation

NCT00834470

Phase 4 Completed 140 enrolled Seoul National University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

* Ketamine seems an obvious choice in the setting of an emergency department * Ketamine leads to increased production of salivary and tracheal secretions * Antisialagogues(atropine)therefore have been recommended as a routine adjunct * We compare atropine with placebo as an adjunct to ketamine sedation in children undergoing primary closure of lacerated wound

Timeline

Start
2008-08
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Atropine Other / unclassified 0.01 mg/kg Intravenous
Background Ketamine Small molecule 2 mg/kg Intravenous

Indications

No indication recorded.